The review article titled"Current insights and future directions in Peyronie's disease management: A narrative review", was ...

Peyronie's disease (PD) causes penile curvature. Its etiology is multifactorial, involving microtrauma and genetic factors.

For patients with opioid use disorder (OUD), evidence supports continuation of buprenorphine during episodes of acute pain, ...

According to a Vertex spokesperson, the drug is seeing strong initial market adoption, with growing payer coverage and ...

In another phase 3 study, patients taking suzetrigine for either surgery or acute pain rated how well they thought it worked. Participants took it every 12 hours for 14 days or until their pain ...

The company's Phase III pivotal programme for patients ... we have the opportunity to change the paradigm of acute pain ...

The Food and Drug Administration has granted Fast Track designation to LTG-001 for the treatment of acute pain.

“With our Phase 3 program for cebranopadol in the treatment of moderate-to-severe acute pain complete, we now have a comprehensive data package that will be submitted to the FDA as the basis for ...

The new data comes from the phase 3 ALLEVIATE-1 trial, which compared cebranopadol to placebo for the management of moderate-to-severe acute pain following full abdominoplasty – a cosmetic ...

The Fast Track designation is supported by data from a phase 1 trial ... its potential to transform the treatment landscape for acute pain by targeting pain at its source,” said Nima Farzan ...